EUVIMED · CrossrefJournal
Pharmacoeconomics and Policy
ISSN 2950-2667 · Elsevier BV
Latest articles
Progress and trends in novel drug R&D: Technological innovation, clinical breakthroughs, and industrial ecosystem restructuring
Pharmacoeconomic evaluation for Chinese medicine products: Progress, challenges, and suggestions
Disease burden of pulmonary arterial hypertension attributable to three factors based on the Global Burden of Disease 2021
Cost-effectiveness analysis of multiple fall prevention interventions for older adults in China: A Markov model approach
Temporal trends and hierarchical disparities of antibiotic utilization patterns: A longitudinal analysis in Shanghai, 2017−2024
Anticipating a regional shift: Preparing the pharmaceutical industry for real-world evidence requirements across East Asia analogous to a Conditional Reimbursement List framework
Ethical compliance of drug promotional literature using WHO criteria: Implications for medicines policy and rational use
Linked pharmacometrics-pharmacoeconomics model for cost-effectiveness analysis of tacrolimus in liver transplant patients from real-world data
Disease burden and productivity loss of T2DM in the Western Pacific region from 1990 to 2050: A modeling study using GBD 2021
Cost-effectiveness of clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review
Comments on the 2025 Edition of China Guidelines for Pharmacoeconomic Evaluations
Current clinical practice including treatment patterns and pathways in idiopathic pulmonary fibrosis patients in China: A real-world analysis
Cost-effectiveness analysis of bevifibatide for patients with acute coronary syndrome undergoing percutaneous coronary intervention in China
Evaluating China's pharmaceutical services policies: An integration of policy tools and policy modeling consistency index analysis
A comparative analysis of EQ-5D-5L general population norms across 23 countries: Gender and age disparities
Physicians’ risk and time preferences and their willingness to detect and disclose genomic secondary findings: A multiple price list experiment
The effect of USA state generic substitution laws on the generic utilization and market competition
The effects of Urgently Needed Overseas Drugs on the launch delay of new drugs in China
Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group
Assessing the suitability of generative AI in the execution of literature retrieval within literature reviews
Keeping up with international frontier and promoting research and development of pharmacoeconomics in China
Launching Pharmacoeconomics and Policy: A new platform for advancing value assessment of health technologies and healthcare innovation
Catastrophic health expenditure and health-related quality of life among patients with chronic diseases: The moderation effect of family doctor contract services
Study on the disease burden and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China
Australian public preferences for the provision of medicinal cannabis: A discrete choice experiment
Impacts of China’s National Volume-Based Procurement policy on the pharmaceutical industry: A systematic review
Economic evaluation of vaccination strategies in China: A systematic review
An empirical study of value evaluation by multi-criteria decision analysis for orphan medicinal product
What is the impact of Inflation Reduction Act negotiated prices for non-insulin diabetes drugs on Louisiana Medicare costs? A forecasting model analysis
Cost-effectiveness of revascularization interventions for patients with stable coronary artery diseases: A critical review of the evidence and methodologies
EUVIMED